28 September 2018
We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Dr Tim Wang at Spire include:
Speciality: Clinical Biochemistry/Chemical Pathology/Metabolic Medicine
Treatments: Hyperlipidaemia / dyslipidaemia (abnormal cholesterol and triglyceride), renal (kidney and bladder) stone disease, calcium metabolism.
I have been a Consultant in Clinical Biochemistry/Metabolic Medicine since 1999 with a particular interest in hyperlipidaemia (abnormal cholesterol and triglyceride), renal (kidney and bladder) stone disease and calcium metabolism.
I specialise in management of conditions with a biochemical basis but in particular in the investigation and treatment of abnormal lipids (cholesterol, triglycerides etc), the investigation of causes and the prevention of renal (kidney, bladder) stones, and the investigation and management of disorders of calcium metabolism.
I am the Specialty Lead for the Clinical and Specialist services for Berkshire and Surrey Pathology Services. I am the Director of the Cardiovascular Biomarkers Laboratory in Guildford, which has Associate Supra-regional Assay Service status. I am on the Steering Group for the National Audit of the Management of Familial Hypercholesterolaemia at the Clinical Effectiveness and Evaluation Unit at the Royal College of Physicians in London. I am a committee member of the Steering group for the Hampshire Familial Hypercholesterolaemia Cascade Service.
In addition to my clinical work, I am also a Visiting Senior Fellow in Metabolic, Endocrine and Nutritional Medicine at the University of Surrey in Guildford.
MB, ChB. PhD / University of Sheffield. University of Cambridge, Addenbrookes Hospital, Cambridge / 1983
Bachelor of Medicine, Bachelor of Surgery. Doctor of Philosophy.
FRCPath Royal College of Pathologists
FRCP Royal College of Physicians
Specialty Lead for the Clinical and Specialist services for Berkshire and Surrey Pathology Services Director of the Cardiovascular Biomarkers Laboratory in Guildford (Associate Supra-regional Assay Service). Steering Group Committee Member for the National Audit of the Management of Familial Hypercholesterolaemia at the Clinical Effectiveness and Evaluation Unit at the Royal College of Physicians in London. Steering Group Member of the Hampshire Familial Hypercholesterolaemia Cascade Service
Consultant, Frimley Park Hospital NHS Foundation Trust, Frimley.
Consultant, Royal Surrey County Hospital NHS Foundation Trust, Guildford.
Visiting Senior Fellow, Faculty of Health and Medical Sciences, University of Surrey, Guildford.
My PhD investigated the control of lipid metabolism in the liver and I have continued in research that is mainly concerning cholesterol.
M Pericleous, C Kelly T Wang, C Livingstone, A Ala. (2017) Wolman’s disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency. The Lancet Gastroenterology and Hepatology 2 (9); 670 - 679
Hannan FM, Rogers A, Howles SA, Cranston T, McKenna M, Richardson T, Babinsky VN, Reed AA, Thakker CE, Bockenhauer D, Brown R, Cook J, Darzi K, Ehtisham S, Graham U, Hulse T, Hunter SJ, Kumar D, McKnight J, Morrison PJ, Mughal Z, Pearce SH, Scheers I, Wang T, Whyte MP, Nesbit MA, Thakker RV. (2015) Adaptor protein-2 sigma subunit mutations in hypercalcemic patients. Human Molecular Genetics 24 (18); 5079-5092
Seed M, Roughton M, Pedersen K, Nair D, Wang T, Neil A, Humphries S. (2012) Current statin treatment, DNA testing and cascade testing of UK patients with familial hypercholesterolaemia. Primary Care Cardiovascular Journal 5; 181-185
Ncube V, Starkey B, Wang T. The effect of fibrate treatment for hyperlipidaemia on serum creatinine and cystatin C. (2012) Ann Clin Biochem 49; 491-493
McKibbin C, Wang T, Wark G. (2017) Tryptic peptide LC-MS/MS: What analytical goals can be achieved in the clinical laboratory? Proceedings of the ACB National Meeting 2017
M Pericleous, C Kelly T Wang, C Livingstone, A Ala. (2017) What is the meaning of low lysosomal acid lipase (LAL) levels in the hepatology and metabolic clinic? Gut 66:A164-A165
Family life is very important to me and I am lucky to have a supportive wife, who manages my clinics but is also a full time physiotherapist, and I am a proud father of 2 daughters who are both at University. I enjoy playing the piano rather badly, and golf and tennis (also badly).Back to top
|Private secretary telephone||01428 712195|
|Private secretary fax||07092 260196|
|Private secretary email@example.com|